Supplwmental results

Figure S1
The control for the primary immune antibodies in the articular cartilage slices. (A) The slices were treated with the same methods of immunochemistry and immunofluorescence without primiray antibodies. (B) The slices were treated with the preimmune antibodies (mouse IgG and rabbit IgG, purchased from Proteintech) instead of the primary immune actibodies, and the other steps were the same as immunochemistry and immunofluorescence. Scale bar = 100 μm.
Figure S2
HPLC-MS analysis of blood 24 h after single intravenous injection of kartogenin (KGN) (2.5 mg/kg) in STR/Ort mice.
Figure S3
Identification of rat bone marrow mesenchymal stem cells by detecting the positive CD44 and CD90, and negative CD45 and CD34 markers by flow cytometry. 
Figure S9
Collagen I and MMP-2 protien expression in umbilical cord mesenchymal stem-cells treated with 4-ABP or KGN for 4 days. **p < 0.01, ***p < 0.001 versus vehicle; ## p < 0.01, ### p < 0.001 versus KGN. n = 3 per group.
